Bioventus Inc. (BVS)

Bioventus Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	36.96	30.19	49.21	86.84	64.52
Cash & Cash Equivalents	36.96	30.19	49.21	86.84	64.52
Cash Growth	22.45%	-38.66%	-43.33%	34.59%	50.84%
Receivables	122.79	136.3	124.96	88.28	85.13
Inventory	91.33	84.77	61.69	29.12	27.33
Other Current Assets	16.91	21.33	27.24	7.55	6.06
Total Current Assets	268	272.58	263.1	211.79	183.03
Property, Plant & Equipment	49.96	44.15	40.17	21.84	19.76
Long-Term Investments	3.14	2.62	79.29	19.38	3.31
Goodwill and Intangibles	489.81	647.31	842.82	241.45	266.31
Other Long-Term Assets	0	405.99	0.48	0	0
Total Long-Term Assets	542.91	1,100	962.76	282.67	289.37
Total Assets	810.91	1,373	1,226	494.47	472.41
Accounts Payable	23.04	36.7	16.92	4.42	6.44
Current Debt	27.85	33.06	18.04	15	10
Other Current Liabilities	124.61	234.26	145.91	103.17	72.58
Total Current Liabilities	175.5	304.02	180.86	122.59	89.02
Long-Term Debt	367	385.01	339.64	173.38	187.97
Other Long-Term Liabilities	47.3	271.4	171.57	54.34	49.81
Total Long-Term Liabilities	414.3	656.41	511.21	227.72	237.78
Total Liabilities	589.79	960.43	692.07	350.31	326.79
Total Debt	394.85	418.07	357.68	188.38	197.97
Debt Growth	-5.55%	16.88%	89.87%	-4.84%	1.61%
Retained Earnings	-321.54	-165.31	-6.6	0	-141.7
Comprehensive Income	0.79	-0.11	0.18	0	-0.47
Shareholders' Equity	173.59	325.24	458.92	144.16	142.98
Net Cash / Debt	-357.88	-387.88	-308.47	-101.54	-133.45
Net Cash Per Share	-5.71	-6.32	-6.78	-20.72	-27.23
Working Capital	92.5	-31.44	82.24	89.21	94.02
Book Value Per Share	2.77	5.30	10.09	29.42	29.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).